Search Results - "Peer, Petronella G.M"

Nationwide Inventory of Risk Factors for Retinopathy of Prematurity in the Netherlands by van Sorge, Arlette J., MD, Termote, Jacqueline U.M., PhD, Kerkhoff, Frank T., PhD, van Rijn, Laurentius J., PhD, Simonsz, Huibert J., PhD, Peer, Petronella G.M., PhD, Schalij-Delfos, Nicoline E., PhD

“…Objectives To study the incidence and risk factors for retinopathy of prematurity (ROP) in the Netherlands. Study design Prospective, approximating…”
Get full text

Determination of exposure to benzene, toluene and xylenes in Turkish primary school children by analysis of breath and by environmental passive sampling by Scheepers, Paul T.J., Konings, Joke, Demirel, Gülcin, Gaga, Eftade O., Anzion, Rob, Peer, Petronella G.M., Dogeroglu, Tuncay, Ornektekin, Sermin, van Doorn, Wim

“…Benzene, toluene, m/p-xylene and o-xylene (BTX) are toxic volatile organic compounds and ubiquitous air pollutants. Smoking and consumer products are indoor…”
Get full text

Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer by Vriens, Birgit E.P.J, de Vries, Bart, Lobbes, Marc B.I, van Gastel, Saskia M, van den Berkmortel, Franchette W.P.J, Smilde, Tineke J, van Warmerdam, Laurence J.C, de Boer, Maaike, van Spronsen, Dick Johan, Smidt, Marjolein L, Peer, Petronella G.M, Aarts, Maureen J, Tjan-Heijnen, Vivianne C.G

“…Abstract Background The aim of this study was to evaluate the accuracy of clinical imaging of the primary breast tumour post-neoadjuvant chemotherapy (NAC)…”
Get full text

Assessment of myocardial velocities in healthy children using tissue Doppler imaging by Kapusta, L, Thijssen, J M, Cuypers, M H, Peer, P G, Daniëls, O

“…The objective was to determine the normal range of tissue velocities in paediatric hearts as measured by tissue Doppler imaging. A prospective study was…”
Get more information

Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium by Seferina, Shanly C., Boer, Maaike, Derksen, M. Wouter, Berkmortel, Franchette, Kampen, Roel J.W., Wouw, Agnès J., Joore, Manuela, Peer, Petronella G.M., Voogd, Adri C., Tjan‐Heijnen, Vivianne C.G.

“…Introduction. We assessed the incidence and timing of first cardiac events, impact on trastuzumab prescription, and role of left ventricular ejection fraction…”
Get full text

Annexin A5 haplotypes in familial hypercholesterolemia: Lack of association with carotid intima-media thickness and cardiovascular disease risk by Hiddink, Larissa, Dallinga-Thie, Geesje M, Hovingh, G. Kees, de Visser, Marieke C.H, Peer, Petronella G.M, Stalenhoef, Anton F.H, van Heerde, Waander L

“…Abstract Objective : Annexin A5 (ANXA5) has been suggested to possess antiatherogenic properties. We investigated whether ANXA5 genetic variations and plasma…”
Get full text

A prediction model to calculate probability of Alzheimer’s disease using cerebrospinal fluid biomarkers by Spies, Petra E, Claassen, Jurgen A.H.R, Peer, Petronella G.M, Blankenstein, Marinus A, Teunissen, Charlotte E, Scheltens, Philip, van der Flier, Wiesje M, Olde Rikkert, Marcel G.M, Verbeek, Marcel M

“…Abstract Background We aimed to develop a prediction model based on cerebrospinal fluid (CSF) biomarkers, that would yield a single estimate representing the…”
Get full text

Marginal maternal vitamin B 12 status increases the risk of offspring with spina bifida by Groenen, Pascal M.W, van Rooij, Iris A.L.M, Peer, Petronella G.M, Gooskens, Rob H, Zielhuis, Gerhard A, Steegers-Theunissen, Régine P.M

“…The purpose of this study was to investigate B vitamins and homocysteine as risk factor for offspring with spina bifida. Blood samples from 45 mothers and…”
Get full text

Comparison of Nodal Risk Formula and MR Lymphography for Predicting Lymph Node Involvement in Prostate Cancer by Deserno, Willem M.L.L.G., M.D., M.Sc, Debats, Oscar A., M.D., M.Sc, Rozema, Tom, M.D, Fortuin, Ansje S., M.D, Heesakkers, Roel A.M., M.D, Hoogeveen, Yvonne, Ph.D, Peer, Petronella G.M., Ph.D, Barentsz, Jelle O., M.D., Ph.D, van Lin, Emile N.J.T., M.D., Ph.D

“…Purpose To compare the nodal risk formula (NRF) as a predictor for lymph node (LN) metastasis in patients with prostate cancer with magnetic resonance…”
Get full text

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial by Tjan-Heijnen, Vivianne C G, van Hellemond, Irene E G, Peer, Petronella G M, Swinkels, Astrid C P, Smorenburg, Carolien H, van der Sangen, Maurice J C, Kroep, Judith R, De Graaf, Hiltje, Honkoop, Aafke H, Erdkamp, Frans L G, van den Berkmortel, Franchette W P J, de Boer, Maaike, de Roos, Wilfred K, Linn, Sabine C, Imholz, Alexander L T, Seynaeve, Caroline M, Kitzen, J.J.E.M., Strobbe, L.J.A., Kouwenhoven, E.A., van Dalen, T., van Overbeeke, A.J., Nuytinck, J.K.S., Arntz, I.E., Blaisse, R.J.B., Stockmann, H.B.A.C., Nijhuis, P.H.A., Veldhuis, G.J., Mastboom, W.J.B., van Riel, J.M.G.H., van Dam, J.H., den Boer, M.O., Agterof, M.J., de Roos, M.A.J., Roumen, R.M.H., van der Hoeven, J.J.M., Beeker, A., Koelemij, R., van Bochove, A., Madretsma, G.S., Siemerink, E.J.M., Guicherit, O.R., Vos, A.H., Nieuwenhuijzen, G.A.P., Kehrer, D.F.S., Valster, F.A.A., Tanis, B.C., van Voorthuizen, T., van der Velden, A.M.T., Hellingman, R.A., Vree, R., van Rossum-Schornagel, Q., Meerum Terwogt, J.M., van Leeuwen-Breuk, W.G., Haasjes, J.G., Davidis-van Schoonhoven, M.A., Vriens, E.J.C., Jagers, M., Muller, E.W., Schiphorst, P.P.J.B.M., van Groeningen, C.J., van Dijk, M.A., Janssens- van Vliet, E., Schepers, E.E.M., Merkus, J.W.S., van Diemen, N.G.J., van Doorn, R.C., Bosscha, K., den Toom, R., van der Velden, P.C., van Rossum, C.T.A.M., Oosterkamp, H.M., van Hillegersberg, R., Jas, B., Weernink, E.E.M., Ketel, J.M.A., Jansen, J.J., Maring, J.K., Govaert, M.J.P.M., Kamm, Y.J.L., Vleugel, M.M., Hovenga, S., de Boer, J., Potthoff, H., Sommeijer, D.W., van Dulken, E.J.

“…The effect of extended adjuvant aromatase inhibition in hormone receptor-positive breast cancer after sequential endocrine therapy of tamoxifen followed by an…”
Get full text

Paediatric Ebstein’s anomaly: how clinical presentation predicts mortality by Geerdink, Lianne M, Delhaas, Tammo, Helbing, Willem A, du Marchie Sarvaas, Gideon J, Heide, Henriette ter, Rozendaal, Lieke, de Korte, Chris L, Peer, Petronella G M, Kuipers, Irene M, Kapusta, Livia

“…BackgroundForecasting the prognosis of a child when diagnosed with Ebstein’s anomaly is difficult. We, therefore, studied which factors at the time of…”
Get full text

Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure by van Hellemond, Irene E G, Vriens, Ingeborg J H, Peer, Petronella G M, Swinkels, Astrid C P, Smorenburg, Carolien H, Seynaeve, Caroline M, van der Sangen, Maurice J C, Kroep, Judith R, de Graaf, Hiltje, Honkoop, Aafke H, Erdkamp, Frans L G, van den Berkmortel, Franchette W P J, Kitzen, Jos J E M, de Boer, Maaike, de Roos, Wïlfred K, Linn, Sabine C, Imholz, Alexander L T, Tjan-Heijnen, Vivianne C G

“…Aromatase inhibitors (AIs) are given as adjuvant therapy for hormone receptor-positive breast cancer in postmenopausal women, also to those with…”
Get full text

Real‐Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium by Seferina, Shanly C., Lobbezoo, Dorien J.A., Boer, Maaike, Dercksen, M. Wouter, Berkmortel, Franchette, Kampen, Roel J.W., Wouw, Agnès J., Vries, Bart, Joore, Manuela A., Peer, Petronella G.M., Voogd, Adri C., Tjan‐Heijnen, Vivianne C.G.

“…Background. The impact of drug prescriptions in real life as opposed to strict clinical trial prescription is only rarely assessed, although it is well…”
Get full text

A review on family history of breast cancer: screening and counseling proposals for women with familial (non-hereditary) breast cancer by Unic, Ivana, Stalmeier, Peep F.M, Peer, Petronella G.M, van Daal, Willem A.J

“…With the aim to specify screening recommendations for women with familial (non-hereditary) breast cancer (FBC) we analysed 59 studies using quantitative…”
Get full text

A Retrospective Cohort Study on the Influence of Comorbidity on Soft Tissue Reactions, Revision Surgery, and Implant Loss in Bone-anchored Hearing Implants by den Besten, Christine A, Nelissen, Rik C, Peer, Petronella G M, Faber, Hubert T, Dun, Catherina A J, de Wolf, Maarten J F, Kunst, Henricus P M, Cremers, Cor W. R J, Mylanus, Emmanuel A M, Hol, Myrthe K S

“…OBJECTIVETo identify risk factors for complications after bone-anchored hearing implant (BAHI) surgery. STUDY DESIGNRetrospective cohort study. SETTINGTertiary…”
Get full text

A Simple Risk Score to Predict the Presence of Non-Sentinel Lymph Node Metastases in Breast Cancer Patients with a Positive Sentinel Node by van la Parra, Raquel F. D., Peer, Petronella G. M., de Roos, Wilfred K., Ernst, Miranda F., de Wilt, Johannes H. W., Bosscha, Koop

“…Background Historically, completion axillary lymph node dissection (cALND) is recommended in sentinel lymph node (SLN)-positive patients. However, the high…”
Get full text

Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study by Bolster, Marieke J, Peer, Petronella G M, Bult, Peter, Thunnissen, Frederik B J M, Schapers, René F M, Meijer, Jos W R, Strobbe, Luc J A, van Berlo, Charles L H, Klinkenbijl, Jean H G, Beex, Louk V A M, Wobbes, Theo, Tjan-Heijnen, Vivianne C G

“…In this multi-institutional prospective study, we evaluated whether we could identify risk factors predictive for non-sentinel lymph node (non-SN) metastases…”
Get full text

Low maternal dietary intakes of iron, magnesium, and niacin are associated with spina bifida in the offspring by Groenen, Pascal M W, van Rooij, Iris A L M, Peer, Petronella G M, Ocké, Marga C, Zielhuis, Gerhard A, Steegers-Theunissen, Régine P M

“…Evidence about the preventive effects of nutrients other than folate on the occurrence of spina bifida is scarce. Therefore, the aim of this work was to…”
Get more information

More tumor‐affected lymph nodes because of the sentinel lymph node procedure but no stage migration, because the 2002 TNM classifies small tumor deposits as pathologic N0 breast cancer by Bolster, Marieke J., Bult, Peter, Wauters, Carla A. P., Strobbe, Luc J. A., Peer, Petronella G. M., Wobbes, Theo, Tjan‐Heijnen, Vivianne C. G.

“…BACKGROUND: Intensified examination of the sentinel lymph node (SN) may result in increased detection of tumor‐affected lymph nodes. The authors of this report…”
Get full text

Differences in sentinel lymph node pathology protocols lead to differences in surgical strategy in breast cancer patients by Bolster, Marieke J, Bult, Peter, Schapers, René F M, Meijer, Jos W R, Strobbe, Luc J A, van Berlo, Charles L H, Klinkenbijl, Jean H G, Peer, Petronella G M, Wobbes, Theo, Tjan-Heijnen, Vivianne C G

“…Internationally, there is no consensus on the pathology protocol to be used to examine the sentinel lymph node (SN). At present, therefore, various hospitals…”
Get full text